Progress in drug therapy for COVID-19 infection
oleh: LIU Fang-yuan, SU Xiu-lan
| Format: | Article |
|---|---|
| Diterbitkan: | Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2020-10-01 |
Deskripsi
The novel coronavirus pneumonia caused by COVID-19 has emerged in Wuhan at the end of Dec. 2019, and then has spread across our country. To date, no specific therapy against the new virus is available. The clinical efficacy of some antiviral drugs, such as remdesivir, chloroquine phosphate, abidor and so on are still need to be further verified. In this article the recent progress on drug therapy for COVID-19 infection is reviewed.